Elevated PD-L1 in glioma cells binds to PD-1 on tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs), creating a suppressive immune microenvironment and resulting in a poor prognosis for GBM patients [64, 65]. The gene discussed is CD274; the disease is neoplasm.